Industry NewsIllumina and Kartos Therapeutics partner to develop an NGS-based TP53 companion diagnostic
Product NewsIllumina launches TruSight Software Suite to accelerate the identification of genetic diseases
Industry NewsFDA authorizes first COVID-19 diagnostic test utilizing next generation sequence technology
Product Newsllumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit
Industry NewsIllumina Announces Strategic Collaboration with Merck Serono to Expand Companion Diagnostics for Oncology
Product NewsIllumina’s MiSeqDxTM Receives FDA Premarket Clearance with Two Cystic Fibrosis Assays and Universal Kit for Open Use
Product NewsIllumina to Supply Natera with Sequencing Instruments and Consumables for Non-Invasive Prenatal Testing (NIPT)
Product NewsHistoGenetics Selects Illumina’s MiSeq® System as Next-Generation Sequencing Platform of Choice
